首页DIVISLAB • NSE
add
Divi's Laboratories Ltd
昨日收盘价
₹6,072.50
当日价格范围
₹5,988.95 - ₹6,105.85
年度波幅
₹3,350.00 - ₹6,275.85
市值
1.60万亿 INR
平均交易量
44.16万
市盈率
86.81
股息率
0.50%
主要交易所
NSE
市场资讯
财务信息
损益表
收入
净收入
| (INR) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 233.80亿 | 22.47% |
经营支出 | 75.20亿 | 5.17% |
净收入 | 51.00亿 | 46.55% |
净利润率 | 21.81 | 19.64% |
每股收益 | 19.51 | 48.82% |
息税折旧摊销前利润 | 71.50亿 | 49.58% |
有效税率 | 29.36% | — |
资产负债表
总资产
负债总额
| (INR) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 360.20亿 | -0.25% |
总资产 | 1558.60亿 | 9.12% |
负债总额 | 186.90亿 | 16.38% |
权益总额 | 1371.70亿 | — |
发行在外的股份 | 2.66亿 | — |
市净率 | 11.76 | — |
资产回报率 | — | — |
资本回报率 | 11.30% | — |
现金流
现金净变动
| (INR) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | 51.00亿 | 46.55% |
来自运营的现金 | — | — |
投资现金 | — | — |
融资现金 | — | — |
现金净变动 | — | — |
自由现金流 | — | — |
简介
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.
In October 2024, Divi and his family were ranked 29th on Forbes list of India’s 100 richest tycoons, with a net worth of $9.2 billion. Wikipedia
CEO
成立时间
1990年10月12日
员工数量
9,741
